BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21479840)

  • 1. Characterization of Candida parapsilosis complex strains isolated from invasive fungal infections.
    Borghi E; Sciota R; Iatta R; Biassoni C; Montagna MT; Morace G
    Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1437-41. PubMed ID: 21479840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan.
    Chen YC; Lin YH; Chen KW; Lii J; Teng HJ; Li SY
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):284-92. PubMed ID: 20851551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.
    Cantón E; Pemán J; Quindós G; Eraso E; Miranda-Zapico I; Álvarez M; Merino P; Campos-Herrero I; Marco F; de la Pedrosa EG; Yagüe G; Guna R; Rubio C; Miranda C; Pazos C; Velasco D;
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5590-6. PubMed ID: 21930869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital.
    Silva AP; Miranda IM; Lisboa C; Pina-Vaz C; Rodrigues AG
    J Clin Microbiol; 2009 Aug; 47(8):2392-7. PubMed ID: 19494078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: Species distribution, antifungal susceptibility and virulence attributes.
    Ziccardi M; Souza LO; Gandra RM; Galdino AC; Baptista AR; Nunes AP; Ribeiro MA; Branquinha MH; Santos AL
    Int J Med Microbiol; 2015 Dec; 305(8):848-59. PubMed ID: 26319940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in candidemia over a 5-year period at Nantes hospital and in vitro susceptibility to three echinocandins by E-test®].
    Thierry G; Morio F; Le Pape P; Gay-Andrieu F; Barre O; Miegeville M
    Pathol Biol (Paris); 2011 Feb; 59(1):52-6. PubMed ID: 20832195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007-2014.
    Lovero G; Borghi E; Balbino S; Cirasola D; De Giglio O; Perdoni F; Caggiano G; Morace G; Montagna MT
    PLoS One; 2016; 11(2):e0150218. PubMed ID: 26919294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and antifungal susceptibility of Candida parapsilosis complex isolates collected from oral cavities of HIV-infected individuals.
    Moris DV; Melhem MSC; Martins MA; Souza LR; Kacew S; Szeszs MW; Carvalho LR; Pimenta-Rodrigues MV; Berghs HAM; Mendes RP
    J Med Microbiol; 2012 Dec; 61(Pt 12):1758-1765. PubMed ID: 22956748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, distribution and antifungal susceptibility profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis bloodstream isolates.
    Bonfietti LX; Martins MDA; Szeszs MW; Pukiskas SBS; Purisco SU; Pimentel FC; Pereira GH; Silva DC; Oliveira L; Melhem MSC
    J Med Microbiol; 2012 Jul; 61(Pt 7):1003-1008. PubMed ID: 22493277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species Distribution, Virulence Factors, and Antifungal Susceptibility Among Candida parapsilosis Complex Isolates Recovered from Clinical Specimens.
    da Silva BV; Silva LB; de Oliveira DB; da Silva PR; Ferreira-Paim K; Andrade-Silva LE; Silva-Vergara ML; Andrade AA
    Mycopathologia; 2015 Dec; 180(5-6):333-43. PubMed ID: 26138435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
    Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G
    J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution, virulence attributes and antifungal susceptibility patterns of Candida parapsilosis complex strains isolated from clinical samples.
    Tosun I; Akyuz Z; Guler NC; Gulmez D; Bayramoglu G; Kaklikkaya N; Arikan-Akdagli S; Aydin F
    Med Mycol; 2013 Jul; 51(5):483-92. PubMed ID: 23216051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Candida parapsilosis complex isolates.
    de Toro M; Torres MJ; Maite R; Aznar J
    Clin Microbiol Infect; 2011 Mar; 17(3):418-24. PubMed ID: 20636431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.
    Blanco-Blanco MT; Gómez-García AC; Hurtado C; Galán-Ladero MA; Lozano Mdel C; García-Tapias A; Blanco MT
    Rev Iberoam Micol; 2014; 31(2):145-8. PubMed ID: 23680638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activities of seven antifungal drugs against clinical isolates of Candida parapsilosis complex.
    Khodavaisy S; Badali H; Meis JF; Modiri M; Mahmoudi S; Abtahi H; Salehi M; Dehghan Manshadi SA; Aala F; Agha Kuchak Afshari S; Lotfali E; Ahangarkani F; Rezaie S
    J Mycol Med; 2020 Sep; 30(3):100968. PubMed ID: 32386800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and echinocandin susceptibility of Candida parapsilosis sensu lato species isolated from bloodstream infections at a Spanish university hospital.
    Garcia-Effron G; Canton E; Pemán J; Dilger A; Romá E; Perlin DS
    J Antimicrob Chemother; 2012 Nov; 67(11):2739-48. PubMed ID: 22868644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular identification and antifungal susceptibility profiles of Candida parapsilosis complex species isolated from culture collection of clinical samples.
    Ataides FS; Costa CR; Souza LK; Fernandes Od; Jesuino RS; Silva Mdo R
    Rev Soc Bras Med Trop; 2015; 48(4):454-9. PubMed ID: 26312937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species,
    Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E
    Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.